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A36 kDn calcium/phospholipid binding protein in human placenta was identified as VAC-fl (annexin-8) by a combination of immunological nd 
pcptide mapping analyses. The protein is a minor product in placenta, accounting for less than 1% of cxtractcd annexins. From 1.40 g of tissue. 
only IO0 ~(6 of rhc protein was isolated. By anion-exchange chromatography on diethylaminorthyl~llulose annexin-t eoeloted with anncxin-3. 
By gel filtration, the protein chromatographcd as a broad peak, where half the product rlutcd as a monomer and half eluted as a hcterodimer that 
was associated with a IO kDa subunit. The combination of anncxin-8 being a minor component in standard anncxin preparations and it co-etuting 
with anncxin-3 by ion exchange chromatography are likely to account for the failure of other labs to chsracterirz tbc product. 
Annexin.8; VAC;O; Lipocortin; Calcium/phospholipid binding protein 
1. INTRODUCTION 
The lipocortins/anncxins are a large family of calcium 
binding proteins that to date have been identified in 
plants, animals, insects, sponges, and slime molds. 
While the physiological functions of annexin-like pro- 
teins are uncertain, their potential involvement in signal 
transduction, membrane trafficking, coagulation, adhe- 
sion, and various facets of inflammation have made 
them key targets for many research programs (for refer- 
ences see refs. 1-3). In humans, 9 distinct genes have 
been identified [4-S]. All share approx. 50% identity. 
Most conserved is the core structure which is made up 
of four repeats (eight in the case of annexin-6) and is 
derived iiom a 70 amino acid unit. The existing gene 
sequences for annexins upport ihat the generic struc- 
ture is generated through duplication. Each protein also 
contains a unique amino terminus (5-167 amino acids 
in length) that confers functional specificity. The re- 
cently published crystal structure for one member of the 
family annexin- [9], has provided further insight into 
our understanding of the properties of the family. 
VAC-p (annexin-8) was first identified in 1989 where 
the original authors in identifying the gene for annexin- 
5 (VAC-a), detected another gene product, cloned it, 
and expressed the protein in E.coli [5]. Since the an- 
nexin-8 mRNA for cloning was obtained from human 
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placenta, placenta seemed to be a likely candidate for 
producing annexin-8. Here we have identified anncxin-8 
in placenta by a combination of Western blotting and 
peptide mapping. The protein (100 pg annexin& g 
tissue) represet,& less than 1% of total annexins in the 
placenta, exphining the difficulty in identifying the 
product. 
2. MATERIALS AND METHODS 
2. I, Marrriu~.s 
Precast 8 x IO cm Dniichi gradient SDS-polyacrylsmide gels wcrc 
from Integrated Separation Systems. Immobilon transfer membrdncs 
were from Millipore. goat anti-rabbit IgG alkalincphosphatasecanju- 
gate from BioRad. and alkaline phosphalasc solor dcvclopmcnt kit 
(NBT, BCIP) from Bethesda Research Labs. Disuccinimidyi s&rate 
was rroni Pierce and iodoacetamidc from Sigma. Anti-lipocortin-3 
antisera was produced in rabbits using bovine @cot-tin-3 as immuno- 
gcn. The anti-liposortind rabbit polyclonal antibody (no. 890) was 
raised with recombinant human lipocortin9. Rabbit anti-VAC@pol- 
yclonal ant&urn raised against recombinant human VAC$ and rc- 
combinant human VAC;Bwerc kindly provided byG.R. Adolf(Ernst- 
Bochringer Institute; Vienna, Austria). 
2.2. Isofatiotr ojatrttrsift-like pi-otritts frorrl plc~co~tu 
Calcittmlphospholipid binding proteins were xtracted from human 
placenta s previously described [IO]. A fresh term human placenta 
was quick frozen on dry ice and stored at -7OOC. I50 g of tissue was 
thawed on ice in 50 mM Tris-HCI pH 7.7, 1 mM C&I,. lOO~g/ml 
soybean trypsin inhibitor, 5 mM benzamidinc, I mM phcnylmethanc- 
sulfonyl fluoride. skinned, and cut into chunks. 250 ml of the butfcr 
was added and the tissue disrupted with a polytron. The homogcnatc 
was centrifuged for 1 h at 4% in a SAG00 rotor (14.000 rpm). Pellets 
were resuspcndcd with a polytron inlo 250 ml of the szmc buffer and 
again centrifuged. After an additional wash, the calcium binding pro- 
teins were extracted with 240 ml of 15 mM N-Zhydroxylpiperazinc- 
K-2.ctbanesulfonic acid pH 7.5.4 mM EDT& 1 mM EGTA. Debris 
was rernovcd by eetttrifugation and the extract loaded onto a 20 ml 
DEAE-cellulose column equilibrated with 25 mM TriseHCl pH 7.7. 
The column was subjected to sequential salt s1ep5 (10, 30, 100, 150. 
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250 mM N&I) in the same buffer, each step consistinp of Iwo- lo-ml 
collections. 0.5 ml from fraction 100-2 was loaded onto a P150 gel 
filtration column (I x 40 cm) in 25 mM Tris-HCI pH 7.7, 1 mM EDTA 
and run at 2 ml/h. Fractions were analyzed for absorbance at280 nm 
and by SDS- PAGE. 
. 
2.3. t4+sleru hlorrif~g 
Proteins or CNBr fragments were subjected to SDS- PAGE and 
either stained with Coomassic brilliant blue. silver-stained [I I] or 
elsctrophoretically transferred to Immobilon (I h. 150 mA) using IO 
mM 3-(cyclohexylamino)propanesulfonic acid pH I 1.25, IO% metha- 
nol as the transfer medium. The blot was blocked with 3% bovine 
serum albumin, 10 mM Tris-HCI pH 7.5. 150 mM NaCl (30 min), 
treated with primary antisera t a I:2000 dilution in blocking buffer 
(1.5 It), then treated with an alkaline phosphatase goat anti-rabbit IgG 
conjugate at a I:2000 dilution in blocking bull’cr. and visualized with 
BRL color development reagent in I hl dicthylamine pH 9.1, 1 mM 
M&I, and 0.1 mM &Cl,. After each antibody step, filters were rinsed 
3 times with Tris-saline and washed 3 times for 10 min with Tris- 
saline. 
3. RESULTS AND DISCUSSlON 
A preparation of calcium binding proteins from 
human placenta was generated by disrupting the tissue 
in buffer containing 1 mM CaCI,, washing the particu- 
late fraction with the same buffer, and then selectively 
extracting the binding proteins with EDTA. Fig. lA, 
lane b shows the product from such a treatment. The 
two prominent bands at 35 and 37 kDa are the four 
domain annexins and the band at 70 kDa is a mixture 
of annexins and residual human serum albumin in the 
preparation. The simple calcium-dependent extraction 
protoccl produced about a loo-fold enrichment of the 
calcium binding proteins. When the EDTA extract was 
subjected to DEAE-cellulose anion-exchange chroma- 
tography, the major protein species of interest were 
fractionated into three pools, a flow-through fraction, 
fraction 100-2+150-l, and fraction 150-2+250-l (Fig. 
IA, lanes c-k). From the Bow-through fraction we pre- 
viously isolated annexins-l (37 kDa), -2 (37 kDa), -4 (35 
kDa), and a dimeric form of annexin-l that had been 
generated by transglutaminase-induced cross-linking 
[lo]. 6 mg of annexin-1, 3 mg of annexin-2, 1 mg of 
annexin- and i .S mg of the annexin- 1dimer were re- 
covered. Similarly, we purified annexin- (35 kDa) from 
fraction lOO-2+150- 1 (lanes h and i) and annexins- (35 
kDa) and -6 (68 kDa) from fraction 150-2+250- 1 (lanes 
j and k). These preparations yielded 1 mg of annexin-3, 
2 mg of annexin-6, and 10 mg of annexin-5. 
Because of our familarity with the placental prepara- 
tion, the same set of samples were probed for annexin-8. 
When the column fractions were subjected to Western 
blotting and probed with anti-annexin- antiserum, the 
results shown in Fig. 1 B were obtained, A prominent 36 
kDa reactive species was detected in fraction 100-2 (lane 
11) that by SDS-PAGE migrated slower than annexin- 
by approx. 1 kDa. This difference in mobility was par- 
ticularly apparent when the position of the signal was 
compared to the position of annexin- (lanes j and k), 
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Fiy. I. Detection of human placental anncxind. Calcium bindial: 
proteins from human placenta were fractionated on a DEAE-cellulose 
column. Aliquots from the column fractions were analyzed by SDS- 
PAGE and either visualized by staining with Coomassie brilliant blue 
(A) or by Western blotting with anti-anncxin-8 polyclonal antisera (D). 
Lanes b-k correspond to co!umn load, flow-through, and salt steps 
containiq, IO, 30-1, 30-2, 100-1, 100-2. 150-1, 150-2, and 250 mM 
NaCI, respectively. In panel A, 40~1 of sample was used for the load 
and flow-through fractions and 10~1 for each ofths alt steps. In panel 
B. one fiflielh of the correspondin samples were loaded. Arrowheads 
mark the position of annexin-8. Lane a, prestained molecular wei@ 
markers. Numbers at the left of the panels denote molecular weights. 
which cross-reacted with the anti-annexin- antisera 
under the blotting conditions used and thus was visunl- 
ized. ‘The tentative identification of annexin- as the 
minor band above annexin- in the coomassie stained 
gel (Fig. 1A) was verified in subsequent analyses. From 
relative band intensities, we inferred that the entire 
preparation contained about 100 ,ug of annexin-8. 
Fraction 100-2 was further fractionated by gel Altra- 
tion (see Fig. 2). When selected column fractions were 
subjected to SDS-PAGE and silver stained, the elution 
profile shown in panel A was obtained. Parallel aliquots 
also were subjected to Western blotting and developed 
with antisera to annexin- (panel B) and annexin- 
(panel C). Annexin- eluted from the column as a single 
peak with apparent size of 35 kDa and annexin- eluted 
as two overlapping peaks with sizes of 35 and 45 kDa. 
The distinctive elution profiles of annexins- and -8 
aided in identifying the corresponding protein bands in 
the silver stained gel (panel A), which are readily appar- 
ent from the analysis. 
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Analysis of annexin- containing fraction by gel filtration. 
DEAE fraction MO-2 was subjected to gel filtration on a PlSOcolumn. 
Column fractions were analyzed by SDS-PAGE and either viaualizcd 
by silver staining (A) or by Wcstcrn blotting. Western blots were 
visualized with annexin- (U) or anncxin-3 (C) antisera. Lanes b-k 
correspond to alternating PI50 column frnctions from fraction I9 10 
fraction 37. 30 ~1 samples were analyzed by silver staining and IO ~1 
samples for the blots. Lane a, prestaincd molecular weight murkcrs. 
Numbers at the left of the panel denote molecular weights. 
The identity of the 36 kDa immunoreactive band as 
annexin- was confirmed by peptide mapping. When gel 
slices containing the 36 kDa placental product and re- 
combinant human annexin- were treated with CNBr 
and the cleavage products analyzed by SDS-PAGE, the 
cleavage profiles were identical (see Fig. 3, lanes d and 
e). The 11 cleavage products that had been detected 
were identical both with respect o position and inten- 
sity. In the same analysis, anncxin-5 was included as a 
control. Only three cleavage products in the annexin-S 
cleavage profile (lane fJ were recognized by the aati- 
annexin- antibody, none were common to annexin-8. 
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Fig. 3. Idcntilication of placental anncxin-8 by peptide mapping. The 
indicated products were subjected to CNBr pepddc mopping as prcri- 
ously described [ I5,lG]. Cicl slices containing 30 ng of placema an- 
ncxin-8 (lanes a. d and g). 30 ng of recombinant human annexin. 
(luncs b,cand h) and 200 ng of human anncxin-5 (lanes c. fand i) were 
treated for I II at 23°C with 0.1 N HCI. 0.2%8-mcrcaptoethanol al ne 
(lanes a-c) or in the presence of 21 mgknl CNI3r (lanes d-i). The gel 
slices were then washed and equilibrated in electrophoresis nmple 
buffer. Cleavage products were clcctrophoresed into a 4-2098 gradient 
gel using the Schaggcr buffer system 1171 and transferred to immo- 
biion. The same blot \vas lirst developed with anti-nnncxin-8 antibody 
(lanes a-f), photographed. and then developed whh an and~annexin-5 
antibody (lanes g-i). The position of molecular weight stundards arc 
indicalcd at the Ml of the panel. 
When the same blot was probed with annexin- anti- 
sera, 12 annexin- cleavage products were observed 
(lane i). The distinct profiles for annexins- (lane i) and 
-8 (lane h) clearly demonstrate that they are unrelated. 
Previously, we analyzed annexins l-6 by CNBr map- 
ping and showed that the CNBr cleavage profle for 
each annexin was distinct [4]. The combination of lim- 
ited proteolysis and Western analysis creates a further 
level of selectivity co the analysis, thereby providing a 
simple diagnostic method for identifying individual an- 
nexins. 
To investigate the nature of the 45 kDa form of an- 
nexin-S that was detected by gel filtration, the 45 kDa 
product was analyzed by SDS-PAGE in the presence 
and absence of reducing agent and after cross-linking 
(Fig. 4). Whereas annexin- in the presence of reducing 
agent migrated on SDS-gels with an apparent mass of 
36 kDa (lane b), the protein’s apparent mass was 45 
kDa in the absence of reducing agent (lane c). The same 
result was obtained if the preparation was treated with 
iodoacetamide prior to analysis (lane f). The shift in 
apparent molecular weight indicated that annexin- 
might be disulfide-linked to a low molecular weight ad- 
duct. The 45 kDa band also was observed when the 
sample was treated with the homobifunctional amine- 
specific cross-linker Disuccinimidyl suberate (DSS). 
supporting an association between annexin- and a 10 
kDa protein. Since the cytoplasmic compartment of 
cells is a reducing environment, it is unlikely that an- 
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Fig. 4. The 45 kDa form of annexin- is a heterodimer, Annexind 
samples at 1.5 fiuglrnl were analyzed by cross-linking either with UY 
light (lane c), DSS (lane d) or oxidation (lanes c and 0. After the 
indicstud treatments samples were suspended in clectrophorcsis sun- 
plc buffer in the presence (lanes a-d) or absence (lanes c and f) of 2% 
2-mercaptoethaaol. Samples were subjected to SDS-PAGE on a lo- 
20% gradient gel, transferred to immobilon, and probed with anti- 
annexin- antibody. For DSS cross-linking, samples in 50 mM trictha- 
nolaminc HCI pH 8,2 were treated with I mM DSS for I h at 23°C. 
For UY cross-linking samples were exposed to a 254 nm UV light (8 
x 10J ,uJ). For oxidation samples were either directly analyzed in the 
absence of reducing agent or treated with 50 mM iodoacetamidc for 
30 min at 73°C and then analyzed. 
nexin-8 is disulfide-linked to another protein. The 
prominence of the 45 kDa form suggests hat annexin- 
may be associated with the 10 kDa protein, but then 
becomes disulfide-linked uring the purification. It re- 
mains to be determined if the association of annexin- 
with the 10 kDa protein is physiologically relevant. De- 
spite a similar content of cysteines in the other annexins, 
we have never seen disulfide-linked forms of any of the 
other family members. Interestingly, during the isola- 
tion of recombinant annexin- from E. coii [S], part of 
the protein had formed a disulfide-linked homodimer. 
Although the relevance of the 45 kDa annexin- is un- 
known, the presence of multiple forms of annexin- 
leads to low yields of the product during purification. 
In the DSS-treated annexin- (Fig. 4, lane d), about 
5% of the signal was associated with a 70 kDa band that 
was absent from parallel samples without DSS treat- 
ment or in samples generated by oxidation and is likely 
to be an annexin- homodimer. Similar findings have 
been described for other annexins [ 10,12,13] and suggest 
that the functional unit for annexin-like proteins may 
be a multimeric adduct. Since for annexin-l we previ- 
ously showed that the major contact point for the asso- 
ciation was the N-terminal tail region [lo], it was of 
interest o determine if annexin- also was associated 
through the tail region. Since three of the first si:r amino 
acids of annexin- are tryptophans, UV cros!r-linking 
was employed for this analysis [14]; however, Caere was 
no identification of a UV light-induced imer (lane c). 
Recently, Tsao et al. [18] published a partial amino 
acid sequence for a 33 kDa protein from rabbit lung 
that they claimed was a new member of the annexin 
family. A comparison of this sequence with sequences 
from the nine known human annexins revealed that the 
best match, S8% identity, was with the first repeat from 
annexin- (see Table I). For the other annexins, identi- 
ties ranged from 36% to 59%. Since the conservation of 
annexin sequences across species typically shows 79% 
identity or more, we conclude that the 33 kDa protein 
probably is rabbit annexin-8. Further studies are needed 
to verify this point. 
In summary, we have identified annexin- as a corn- 
ponent of human placenta by a combination of peptide 
mapping and immunological analyses. The small 
amount of annexin- in the tissue, its coelution with 
annexin- on DEAE-cellulose, and its presence in mul- 
Table I 
Alignment of rabbit 33 kDa PLBP and human annexin sequences. 
Source Sequence Identity 
33 kD PLBP 
ANNEXIN. l 
ANNEXIN.? 
ANNEXIN. 
ANNEXiN- 
AKNEXIN-5 
ANNEXIN& 
AKNEXIN-Bb 
ANNEXIN- 
ANNEXIN- 
ANNEXIN- 
T~,.VK.VD.AT...I..K.NN . . ..iWAYLQET.KP.D.T 41.5% 
I.TK.VD.VT.VNI..N..N . ..D..FAYQRRTKKE.ASA 36.6% 
IA . ..D.~L.SI..E..N....L.V.EYQ.AY.KE.I<D. 48.8% 
,..L..D.D... S..AY.NT..,. E.RTAY.STI.R..ID. 53.7% 
. .L..D.SS.LTL..S..f\f....E.SAA,.TL..R..LD. 56.1% 
* * . F.SDKE..L.If.S..NR.,.EVCQ.Y.SLY.K..IA. 46.3% 
. .L..D.DT...II.H..~~.....RQT..Sf~..R..MT. 58.5% 
. .F..D.. ..V..VAN..ND.. .K.KAA,.TSY.K..IK. 56.1% 
.,,.......,..... K..NT..............K....T 87.8% 
C..M....A . .ZI.SG.T.DE....KQKY..TY.KE.E.V 51.2% 
Thr: 41 amino acid sequence from 33 kDa PLBP [IS] WAS aligned with the corresponding segment of the first repeat unit from each of the known 
human anncxins [4-S]. Dots (.) indicate conserved amino acids. Percent identities between the peptidc and the different anncxins arc given. For 
anaexin-6, the first (Ga) and fifth (Gb) repeats are shown. Anncxin-(IS) refers to the newly discovered intestine-specific annexin [6]. The PLBP 
sequence also was compared to 55 kDa bovine nnncxin-Xl [19] to which it showed G3% identity. 
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tiplc forms are likely to have contributed to it being 
missed in previous studies. While the true function of 
annexin- is unknown, the recent discovery of tissue 
specific annexins [G], raises the possibility that it to may 
also be specific for a certain cell type. Thus it will be 
important o determine the cell types that express an- 
nexin-8. Annexins in exhibiting potent activities in di- 
verse biological systems have and continue to be impor- 
tant targets for a wide range of research programs. 
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